Multinational companies (MNCs) were increasing investment allocations to sectors such as high-end manufacturing, healthcare and pharmaceuticals, David Liao Yi-chien said on Tuesday, adding that MNCs also remained optimistic about consumption-related industries like fast-moving consumer goods.
This reorientation reflected how global companies were “positioning China as a global market for driving innovation, consumption and growth”, he said at the 25th China International Fair for Investment and Trade (CIFIT) in Xiamen, in southeastern China’s Fujian province.
China ranked as the top target market for companies looking to increase their global trade capabilities, according to HSBC’s Global Trade Pulse Survey, which polled more than 5,700 multinational companies earlier this year. China was a primary focus for 44 per cent of the respondents, and around 40 per cent said they were increasing or planning to increase their manufacturing in China over the next two years.
The world’s second-largest economy, China continued to attract international investment thanks to its “vast market size, comprehensive industrial facilities, a dynamic innovation ecosystem and abundant talent”, Liao said.
China’s capital markets provided indispensable investment opportunities for international investors, particularly as “innovation-driven economic growth” continued to draw global attention, he said.
